Haemonetics Corporation (HAE)

Exchange
NYSE
Symbol
HAE
Sector
Life Sciences
Industry
Surgical & Medical Instruments & Apparatus
Description
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
Country
USA

Stock price

At close: November 21, 2024

  • Open
    85.25
  • High
    86.68
  • Low
    84.42
  • Close
    85.43
  • Volume
    566,874

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
3.60
Receivables turnover
12.57
Payables turnover
15.55
Working capital turnover
5.54
Days of inventory on hand (DOH)
101.49
Days of sales outstanding (DSO)
29.04
Number of days of payables
23.47
Fixed asset turnover
8.34
Total asset turnover
1.18
 Liquidity ratios
Current ratio
2.56
Quick ratio
1.28
Cash ratio
0.60
Cash conversion cycle
107.06
 Solvency ratios
Debt-to-assets ratio
0.36
Debt-to-capital ratio
0.45
Debt-to-equity ratio
0.83
Financial leverage ratio
2.29
Interest coverage
8.46
 Profitability ratios
Gross profit margin
26.64%
Operating profit margin
6.35%
Pretax margin
5.85%
Net profit margin
4.53%
Operating return on assets (Operating ROA)
7.51%
Return on assets (ROA)
5.35%
Return on total capital
9.38%
Return on equity (ROE)
12.25%